Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines.
Geeleher P, Cox NJ, Huang RS. · 2014
Read Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. by Geeleher P, Cox NJ, Huang RS. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4054092.txt.
Description
Paul Geeleher, Nancy J. Cox, and R. Stephanie Huang predict how patients will respond to chemotherapy using models trained on cell lines, in Genome Biology in 2014. Response to cancer drugs varies wildly and side effects can kill, yet few markers predict who benefits.
Their method learns from a large panel of cell lines, fitting whole-genome expression against measured drug sensitivity and letting every gene speak. After cleaning and matching the data, the cell-line models are applied to a patient's tumour expression before treatment. The output is a forecast of drug response in the body. Tested on three independent clinical trial data sets, the forecasts matched or beat signatures built from patient data itself. The approach turns the huge cell-line screening archives into a clinical tool. It also sidesteps the need for a fresh marker hunt for each drug and cancer pairing.
Catalog record
| CREATOR | Geeleher P, Cox NJ, Huang RS. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |